SIREN : 803611128
MSLAB is a French company founded 11 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in PARIS (75017), this company of category PME shows in 2022 a revenue of 2.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2022 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|
| Revenue | 2 007 296 € | 1 173 057 € | 1 425 878 € | 787 211 € | 993 166 € | 761 174 € | 573 324 € |
| Net income | 10 343 € | 27 618 € | 36 750 € | 21 507 € | 132 € | 34 099 € | 27 421 € |
| EBITDA | -62 169 € | 29 070 € | 45 667 € | 21 366 € | -16 923 € | 54 039 € | 32 314 € |
| Net margin | 0.5% | 2.4% | 2.6% | 2.7% | 0.0% | 4.5% | 4.8% |
In 2022, MSLAB achieves revenue of 2.0 M€. Over the period 2015-2022, the company shows strong growth with a CAGR (compound annual growth rate) of +19.6%. Vs 2020, growth of +71% (1.2 M€ -> 2.0 M€). After deducting consumption (948 k€), gross margin stands at 1.1 M€, i.e. a rate of 53%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches -62 k€, representing -3.1% of revenue. Warning negative scissor effect: despite revenue change (+71%), EBITDA varies by -314%, reducing margin by 5.6 pts. This reflects costs rising faster than revenue. Negative EBITDA means operations do not cover current expenses: concerning situation. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 10 k€, i.e. 0.5% of revenue. This profit can be retained or distributed to shareholders.
2 007 296 €
1 058 979 €
-62 169 €
-73 593 €
10 343 €
-3.1%
The debt ratio (= Financial debt / Equity x 100) stands at 221%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 22%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 27.5 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high. Cash flow represents 1.0% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
220.835%
21.606%
1.041%
27.549
91.7%
In 2022, the debt ratio of MSLAB (220.84) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2022, the financial autonomy of MSLAB (21.6%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2022, the repayment capacity of MSLAB (27.55) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
The liquidity ratio (= Current assets / Current liabilities) stands at 261.38. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
261.375
-1.792
In 2022, the liquidity ratio of MSLAB (261.38) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2022, the interest coverage of MSLAB (-1.8x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 98 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 18 days. The gap of 80 days means the company finances its customers for over a month before being paid relative to supplier payments. This weighs on cash flow. Inventory turnover is 4 days (= Average inventory / Cost of goods x 360). Fast turnover, sign of good inventory management. Overall, WCR represents 84 days of revenue, i.e. 471 k€ to permanently finance. Over 2015-2022, WCR increased by +331%, requiring additional financing.
470 912 €
98 j
18 j
4 j
84 j
Based on 124 transactions of similar company sales (all years), the value of MSLAB is estimated at 259 900 € (range 140 388€ - 789 359€). The price/revenue ratio is 0.21x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare MSLAB with other companies in the same sector:
The revenue of MSLAB in 2022 is 2.0 M€.
Yes, MSLAB generated a net profit of 10 k€ in 2022.
The headquarters of MSLAB is located in PARIS (75017), in the department Paris.
The tax return of MSLAB is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
MSLAB operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.